September 01, 2014 11:03 PM ET

Pharmaceuticals

Company Overview of Biotie Therapies AG

Company Overview

Biotie Therapies AG offers drug development services focusing on neurology and psychiatry. Its SYN-118 product is a therapy for advanced Parkinson's disease patients. The company also provides clinical development programs and research services. It has a strategic partnership with UCB SA. Biotie Therapies AG was formerly known as Synosia Therapeutics AG and changed its name to Biotie Therapies AG in February 2011. As a result of its acquisition by Biotie Therapies Oyj, the name of Synosia Therapeutics AG was changed. The company was founded in 2005 and is based in Basel, Switzerland. As of February 2, 2011, Biotie Therapies AG operates as a subsidiary of Biotie Therapies Corp.

Aeschenvorstadt 36

Basel,  4051

Switzerland

Founded in 2005

Phone:

41 61 206 92 02

Fax:

41 61 206 92 01

Key Executives for Biotie Therapies AG

Chief Executive Officer
Age: 63
Co-Founder and Chief Medical Advisor
Age: 66
Co-Founder and Chairman of Scientific Advisory Board
Chief Financial Officer
Chief Business Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cilag AG International Zug Europe
Arena Pharmaceuticals GmbH Europe
SDI Diagnostics International Ltd Europe
Bayer Consumer Care AG Europe
United Pharma LTD. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biotie Therapies AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.